派特灵强化科研布局

Core Viewpoint - The company, Paiteling, aims to enhance the HPV negative conversion rate as its core objective for the new year, focusing on optimizing service quality in the field of HPV and cervical cancer prevention [1][3]. Group 1: Company Strategy - Paiteling has over 30 years of experience in the HPV virus prevention field and is increasingly recognized for its work, which has been discussed at international academic conferences as a "Chinese solution" [1]. - The brand emphasizes the importance of the negative conversion rate and focuses on intervention at the source of infection, rather than just addressing diseases caused by HPV [3]. - The company is exploring the integration of traditional Chinese medicine with modern medical practices, collaborating with hospitals and clinical experts to develop combined prevention and treatment pathways [3]. Group 2: Research and Development Focus - In the upcoming year, Paiteling plans to invest in research to enhance product experience and address weaknesses in the HPV prevention chain, such as incomplete vaccine protection and timely screening [5]. - The company aims to provide more tools and solutions for intervening in HPV infections, particularly for high-risk persistent infections, to alleviate anxiety among infected individuals and support those needing early intervention [5]. - Paiteling will strengthen research on combined treatment plans, promoting the deep integration of traditional Chinese medicine with modern medical practices, reflecting the brand's commitment to health management and cultural heritage [5].